SCHEMBL32669600

SCHEMBL32669600

Cc1ccc(F)c(CN(C)C(=O)/C(C#N)=C(\O)c2cc(Cl)c(O)c(Cl)c2)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
POLB P06746 1/20 0.39
MAPT P10636 1/20 0.39
GALK1 P51570 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
COMT P21964 1/20 0.38
FTO Q9C0B1 1/20 0.38
HSD17B13 Q7Z5P4 1/20 0.34
KDM4E B2RXH2 2/20 0.33
PTGS2 P35354 2/20 0.33
ABCB11 O95342 1/20 0.33
PTGS1 P23219 1/20 0.33
PPARG P37231 1/20 0.33
NR1I3 Q14994 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
MAOA P21397 1/20 0.32
MAOB P27338 1/20 0.32
SLC22A12 Q96S37 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32670105 0.93 ALDH1A1 (0.37) ALDH1A1MEN1KMT2APOLBMAPT
SCHEMBL32669847 0.92 COMT (0.39) ALDH1A1MEN1KMT2APOLBMAPT
SCHEMBL32669988 0.90 COMT (0.52) ALDH1A1MEN1KMT2APOLBMAPT
SCHEMBL32669942 0.89 MEN1 (0.36) ALDH1A1MEN1KMT2APOLBMAPT
SCHEMBL32669621 0.89 COMT (0.37) ALDH1A1COMTFTOHSD17B13MAOA
SCHEMBL32669498 0.88 COMT (0.39) ALDH1A1MEN1KMT2APOLBMAPT
SCHEMBL32669970 0.88 MEN1 (0.39) ALDH1A1MEN1KMT2APOLBMAPT
SCHEMBL32669758 0.87 COMT (0.36) ALDH1A1MEN1KMT2APOLBMAPT
SCHEMBL32670065 0.87 MCL1 (0.38) MEN1KMT2APOLBMAPTCOMT
SCHEMBL32669743 0.87 MEN1 (0.39) ALDH1A1MEN1KMT2APOLBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260035341-A1 FTO INHIBITORS RPXDS CO LTD (CN) 2026-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260035341-A1 FTO INHIBITORS FTO, LDLR, GPR119 ALDH1A1 1334/4885MEN1 3974/4885KMT2A 567/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.